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A B S T R A C T
Myocardial hibernation denotes chronic ventricular dysfunction, regional and/or 
global, due to myocardial ischemia usually due to ischemic heart disease. A postu-
lated mechanism may be relayed to subacute or chronic myocardial ischemia resulting 
from a reduction of coronary blood flow. Techniques to detect and quantitate the 
extent of viable myocardium may include nuclear imaging and 18-fluorodeoxyglucose 
positron emission tomography (FDG PET). When a sufficient amount of viable myo-
cardium is present, surgical or percutaneous revascularization appears to be effective 
in relieving symptoms and improving left ventricular function and prognosis even in 
patients with a very low ejection fraction. Thus, detection of viable hibernating myo-
cardium is highly desirable before revascularization is undertaken.
D e f i n i T i o n  o f  h i B e R n A T i n g  m y o C A R D i u m
Myocardial hibernation is a condition of chronic ventricular dysfunction, regional 
and/or global, due to myocardial ischemia usually due to ischemic heart disease. The 
term “hibernation” referring to this condition was first coined by Diamond et al. in 
1978 1 but was not widely recognized until Rahimtoola documented the importance of 
this condition, particularly in relation to potential improvement of ventricular function 
following myocardial reperfusion therapy. 2
P o T e n T i A l  m e C h A n i S m S
The precise mechanisms of myocardial hibernation have not been established. 
It has been postulated that it results from subacute or chronic myocardial ischemia 
resulting from a reduction of coronary blood flow. There is a compensatory concur-
rent reduction in myocardial oxygen and metabolic demand in the affected myocar-
dial segments. For example, it has been hypothesized that the myocardial contractile 
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function decreases to match the reduction of coronary blood 
flow. It has been also suggested that hibernation results from 
repetitive episodes of ischemia/reperfusion resulting from an 
imbalance between myocardial metabolic demand and oxygen 
supply, which cannot increase appropriately due to impaired 
coronary flow reserve. This imbalance causes repetitive epi-
sodes of mechanical dysfunction and eventually hibernating 
myocardium.
The precise biochemical and cellular mechanisms of 
myocardial hibernation in humans has not been clarified. In 
animal models the accumulation of glycogen, alteration of 
calcium regulation and some extent of cell degeneration have 
been shown. However, in both animal models and patients 
with myocardial hibernation, increased expressions of several 
survival genes have been demonstrated. For example, the 
inhibitor of apoptosis and cytoprotective heat-shock proteins 
are significantly up-regulated in the hibernating myocardium.3 
The potential mechanisms are illustrated in Figure 1.
Chronic coronary artery disease –Coronary stenosis
Decreased or maintained coronary blood flow at rest.
Decreased metabolism Demand ischemia
Decreased function Chronic stunning
Chronically decreased contractile function
Genomic trigger of cell survival
Proteins of survival (IAP, HSPs)
figuRe 1. (adapted from reference 3). Hibernation: Survival 
hypothesis. HSPs = heat-shock proteins; IAP = inhibitor of 
apoptosis protein.
D e T e C T i o n  A n D  D i A g n o S i S  
i n  C l i n i C A l  P R A C T i C e
A number of non-invasive techniques are in use for 
detection of hibernating myocardial segments, including 
dobutamine echocardiography; thallium-201 imaging; use 
of technetium-99m labeled agents; 18-fluorodeoxyglucose 
positron emission tomography (FDG PET) and magnetic 
resonance imaging (MRI). All these different imaging modali-
ties have been used rather extensively with the same objective 
of predicting improvement in regional and global myocardial 
function, in symptoms of heart failure and quality of life and 
in prognosis.
P R e D i C T i o n  o f  R e C o v e R y  
o f  R e g i o n A l  f u n C T i o n
D o B u T A m i n e  e C h o C A R D i o g R A P h y  ( D e )
In clinical practice, both low- dose and high -dose dobu-
tamine echocardiography (DE) are performed. Low- dose 
DE allows assessment of changes in contractile function and 
high-dose DE allows assessment of both contractile reserve 
and stress-induced myocardial ischemia. For prediction of 
recovery of regional function, low-dose DE has a sensitivity 
and specificity of 79 and 78%, with a positive predictive value 
and negative predictive value of 76 and 82%. High-dose DE 
has a sensitivity and specificity of 83 and 79%, with a positive 
and negative predictive values of 73 and 85% respectively. 
High-dose DE has a significantly higher sensitivity and nega-
tive predictive value than low-dose DE. 4
T h A l l i u m - 2 0 1  i m A g i n g  ( T i - 2 0 1)
Usually two TI-201 protocols, rest-redistribution and re-
injection are used to assess ischemic viable myocardium. The 
rest-distribution technique has a sensitivity and specificity of 
87 and 56% with positive and negative predictive values of 71 
and 78% respectively. The TI-201 reinjection protocol has 
a sensitivity and specificity of 87 and 50% and positive and 
negative predictive values of 58 and 81%. Thus, TI-201 rest-
redistribution appears to have significantly higher specificity 
and positive predictive value than TI-201 reinjection protocol. 4
T e C h n e T i u m  - 9 9 m  l A B e l e D  A g e n T S
The use of technetium-99m labeled agents yields a sensi-
tivity and specificity of 83 and 65%, and a positive and nega-
tive predictive value of 74 and 76% respectively. The use of 
technetium-99m labeled agents without the addition of nitrates 
yielded a sensitivity and specificity of 83 and 57% and a posi-
tive and a negative predictive value of 72 and 71% respectively. 
With addition of nitrates, the sensitivity and specificity are 81 
and 69% and the positive and negative predictive values of 
72 and 78%. Nuclear imaging with technetium-99m labeled 
agents with addition of nitrates appears to have a higher 
specificity and negative predictive value than without nitrates. 4
1 8 - f l u o R o D e o x y  g l u C o S e  P o S i T R o n 
e m i S S i o n  T o m o g R A P h y  ( f D g  P e T )
FDG PET imaging studies are increasingly performed for 
identification of viable myocardium. The sensitivity and speci-
ficity of FDG PET are 92 and 63% and positive and negative 
predictive values of 74 and 87% respectively.
m A g n e T i C  R e S o n A n C e  i m A g i n g  ( m R i )
Magnetic resonance imaging (MRI) is being increasingly 
used to assess myocardial viability. Resting MRI can be used 
to determine wall thickness and contractile function at rest. 
Myocardial segments with an end-diastolic wall thickness 
<6 mm usually indicate transmural scar and the function 
of these segments does not improve after revascularization. 
Dobutamine MRI is used to assess contractile reserve. Con-
trast-enhanced MRI using gadolinium-based contrast agents 
permits detection of the extent and transmurality of scar tissue.
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MRI using end-diastolic wall thickness appears to have 
sensitivity and specificity of 95 and 41% and positive and 
negative predictive values of 56 and 92%. The sensitivity and 
specificity of dobutamine MRI are 74 and 82% and both posi-
tive and negative predictive values 78%. Contrast-enhanced 
MRI has a sensitivity and specificity of 84 and 63% and posi-
tive and negative predictive values of 72 and 78%.
Comparison of these techniques for the prediction of 
improving the regional function of hibernating myocardial 
segments suggest that FDG PET has the highest sensitivity 
followed by TI-201 imaging and technetium-99m labeled 
agents. In general, nuclear imaging techniques have a higher 
sensitivity than DE. However, DE appears to have highest 
specificity. The DE and FDG PET also have the highest posi-
tive predictive value. On the other hand, FDG PET has the 
highest and nuclear imaging with technetium -99m labeled 
agents the lowest negative predictive value.
P R e D i C T i o n  o f  R e C o v e R y  
o f  g l o B A l  S y S T o l i C  f u n C T i o n
It should be emphasized that in different studies using the 
same technique, and in the studies using different techniques, 
a wide variety and variable criteria have been used to assess 
changes in the global left ventricular systolic function.
The DE appears to have an approximate sensitivity and 
specificity of 57 and 73%, and positive and negative predic-
tive values of 63 and 68%. The TI-201 imaging studies have a 
sensitivity and specificity of 84 and 53% and the positive and 
negative predictive values of 76 and 64% respectively. Only 
limited studies have been done with the use of technetium 
-99m labeled agents to assess changes in left ventricular global 
function after revascularization. The sensitivity and specificity 
appear to be 84 and 68% and the positive and the negative 
predictive values of 74 and 80%. The FDG PET studies have 
the sensitivity of 83 and 64% with positive and negative pre-
dictive values of 68 and 80%. One contrast-enhanced MRI 
study, 5 reported that the greater the amount of dysfunctional 
myocardium detected, the greater is the increase in ejection 
fraction after revascularization. The comparison of these vari-
ous imaging modalities appear to have very similar positive 
and negative predictive values to predict the improvement of 
global left ventricular function after revascularization.4
P R e D i C T i o n  o f  i m P R o v e m e n T  
o f  S y m P T o m S  o f  h e A R T  f A i l u R e  
A n D  e x e R C i S e  C A P A C i T y
Only very few studies using these various imaging modali-
ties have investigated and reported changes in heart failure 
severity after revascularization. In general, in patients with 
viable myocardium NYHA functional class tends to improve 
and in absence the functional class does not change. 4
C h A n g e S  i n  P R o g n o S i S
When DE was used, the patients with viable myocardium 
undergoing surgery had the best survival rates whereas the 
highest annualized mortality rates were noted in patients 
receiving medical therapy or without viable myocardium.
The TI-201 imaging studies have reported that the patients 
with viable myocardium had the best survival after revascu-
larization whereas the annualized mortality was highest in 
patients with non viable myocardium. Intermediate mortality 
rates were observed with medical therapy. Very limited studies 
are available where technetium-99m labeled agents were used 
to assess prognosis. In one study, during a follow-up period 
of 40 months, the annualized mortality rate in patients with 
viable myocardium was 3% after successful revascularization 
as compared to 9% in patients who received medical therapy. 6 
The FDG PET studies have also reported that in patients with 
viable myocardium the annualized mortality rates are lowest 
after revascularization and highest in patients without viable 
myocardium. The annualized mortality rate is intermediate 
with medical therapy. 4
It should be appreciated that the results of all these stud-
ies reporting change of prognosis after revascularization are 
based on retrospective analysis. Furthermore, when the results 
of revascularization have been compared to those of medical 
therapy, the aggressive treatment for coronary artery disease 
and left ventricular dysfunction were not available.
Does regional and global left ventricular systolic function, 
symptoms and prognosis improve after revascularization in 
patients with left ventricular systolic dysfunction?
That both myocardial metabolic and left ventricular re-
gional and global mechanical function improves after revas-
cularization was reported within a few years of introduction 
of coronary artery bypass graft surgery. 7-9 In these studies, 
however, most patients had only mildly or moderately reduced 
ejection fraction. However, recently more and more patients 
with markedly reduced ejection fraction are undergoing 
revascularization. It is therefore relevant to be familiar with 
the results of revascularization in these patient populations 
and what factors are likely to be associated with improved 
prognosis.
In the coronary artery surgery (CASS) registry, there were 
651 patients who had left ventricular ejection fraction of < 
35%. The five year survival rate was significantly better in 
surgical patients (68%) compared to patients treated medically 
(54%). The benefit from surgery was greater in patients with 
left ventricular ejection fraction (LVEF) of < 26%. Five-year 
survival with surgery (63%) was significantly higher than that 
with medical treatment (43%). 10 Many studies have been 
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performed since then and reported benefits of revasculariza-
tion in certain subsets patients with reduced ejection with or 
without angina and with or without overt heart failure. Various 
predicting factors have also been proposed to identify patients 
who are likely to benefit.
In a recent study, it was also reported that operative 
mortality is related to a number of risk factors. The conven-
tional coronary artery bypass surgery (LVEF 30.1%) and 
of pump techniques (LVEF 27.5%) have little influence on 
the mortality but as expected, the morbidity was higher with 
conventional technique (35.7%) compared to the off-pump 
technique (19.7%). The risk factors were urgency of surgery 
and co-morbidities.11
It has been previously reported that revascularization is 
beneficial in patients with low LVEF whose presenting symp-
tom is angina and it is unlikely to benefit patients present with 
symptoms of heart failure without angina. However, recent 
studies have reported that the benefit in terms of improvement 
of ventricular function and long-term prognosis depends on 
the magnitude of viable myocardium present before revascu-
larization. If the extent of viable myocardium is about 70% 
of the left ventricle, symptomatic improvement, improvement 
in ventricular function and prognosis is similar whether 
the presenting symptom is angina or heart failure, whether 
revascularization is by coronary artery bypass surgery or by 
percutaneous intervention. The three-year survival of patients 
with angina and viable myocardium in the angina group was 
89% and in the heart failure group 87%.12
Conclusions. A substantial increase in the understanding 
of the mechanism of hibernation and its detection has oc-
curred recently. A large number of studies identify the best 
technique to detect and quantitate the extent of viable ischemic 
dysfunctioning myocardium, and it appears that nuclear imag-
ing and FDG PET are both useful in clinical practice. Revas-
cularization, whether by coronary artery bypass surgery or by 
percutaneous coronary intervention, appears to be effective 
in relieving symptoms and improving left ventricular function 
and prognosis even in patients with a very low ejection fraction, 
provided a sufficient magnitude of viable of myocardium is 
present. Thus, detection of viable hibernating myocardium is 
highly desirable before revascularization is undertaken.
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